ArticleMolecular oncology2026
RETRACTION: LncRNA AATBC Regulates Pinin to Promote Metastasis in Nasopharyngeal Carcinoma.
Article in Molecular oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Retraction of
Authors and funding
0 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
retractionT. Tang, L. Yang, Y. Cao, M. Wang, S. Zhang, Z. Gong, F. Xiong, Y. He, Y. Zhou, Q. Liao, B. Xiang, M. Zhou, C. Guo, X. Li, Y. Li, W. Xiong, G. Li, and Z. Zeng, "LncRNA AATBC Regulates Pinin to Promote Metastasis in Nasopharyngeal Carcinoma," Molecular Oncology 14, no. 9 (2020): 2251-2270, https://doi.org/10.1002/1878-0261.12703. The above article, published online on 4 May 2020 in Wiley Online Library (https://onlinelibrary.wiley.com/), has been retracted by agreement between the journal Editor-in-Chief, Kevin M. Ryan; the Federation of European Biochemical Societies; and John Wiley & Sons Ltd. The retraction has been agreed due to concerns raised by third parties. Specifically, image elements in Figures 2D and 2G were found to have been previously published by the author group in different scientific contexts. Furthermore, the GAPDH blots derived from the CNE2 cells for the "NC" and "siPNN" groups in Figure 4B, and for the "NC" and "1237-3p" groups in Figure 5C were found duplicated. In addition, overlapping regions were identified between the panels depicting the "NC" and "siAATBC + PNN" groups within the CNE2 lane. While the authors acknowledged the errors and supplied raw data in support of their response, the editors deemed the clarification insufficient to address their concerns. The authors attributed the mistakes to similarities between the affected images, raising concerns over the accuracy of the data presented in the remaining body of the article. Furthermore, further review determined that the vast majority of the cited references were self-citations, many of which were found to be irrelevant or only marginally relevant to the context at hand, resulting in several statements lacking adequate support from the literature. Accordingly, the article has been retracted, as the editors have lost confidence in the reliability of the results and conclusions presented. The authors have been informed of the retraction decision, but were not available for final confirmation.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.